BioSpace News Archive

Compass Therapeutics, Inc. (OTCQB: CMPX), a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies, today announced that Thomas Schuetz, MD, PhD, Co-Founder and Chief Executive Officer of Compass Therapeutics, will participate in the following virtual investor conferences:

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Actemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), a debilitating condition with limited treatment options.

Neovasc, Inc. will report results for the fourth quarter and fiscal year ended December 31, 2020 after the market close on Thursday, March 11, 2021.

Bioventus Inc., a global leader in innovations for active healing, has appointed Larry Chen as Managing Director, China and Asia Pacific.

Meridian Bioscience, Inc., a provider of diagnostic testing solutions and life science raw materials, announced its participation in the H.C. Wainwright Global Life Sciences 2021 Virtual Conference.

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, announced that it has received shipment of a new batch of Adva-27a from its manufacturer in China.

Capricor Therapeutics, Inc., a biotechnology company focused on the development of first-in-class cell- and exosome-based therapeutics for the treatment and prevention of a variety of diseases and disorders will release its financial results for the fourth quarter and full year ended December 31, 2020, shortly after the NASDAQ market close on Thursday, March 11.

GI Alliance, one of the nation’s largest independent gastroenterology services organizations, announced further expansion in Texas through a partnership with Austin Gastroenterology.

AccessDX Laboratory (“AccessDX Lab”), a national provider of COVID-19 testing services and advanced laboratory diagnostics, has announced the immediate availability of its investigational COVID-19 variant detection capabilities.

Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its fourth quarter and full year 2020 financial and operating results on Thursday, March 11, 2021 before the market opens.